Neutralizing antibodies in gene-defective hosts (Q35053404)

6 August 2017

1 reference

title

Neutralizing antibodies in gene-defective hosts (English)

1 reference

6 August 2017

1

Ghislain Opdenakker

0 references

Geneviève Laureys

3

object named as

Geneviève Laureys

0 references

author name string

Philippe E Van den Steen

2

1 reference

PubMed ID

12547507

6 August 2017

Kathleen Hunninck

4

1 reference

PubMed ID

12547507

6 August 2017

Bernd Arnold

5

1 reference

6 August 2017

1 February 2003

1 reference

6 August 2017

1 reference

6 August 2017

24

1 reference

6 August 2017

2

1 reference

6 August 2017

94-100

1 reference

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2900037-6

7 January 2021

Clinical research. Gene therapy a suspect in leukemia-like disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2900037-6

7 January 2021

Natural antibodies and complement link innate and acquired immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2900037-6

7 January 2021

Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2900037-6

7 January 2021

Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2900037-6

7 January 2021

Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2900037-6

7 January 2021

Phenotypic expressions of CCR5-delta32/delta32 homozygosity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2900037-6

7 January 2021

Anti-CCR5 antibodies in sera of HIV-positive individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2900037-6

7 January 2021

Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2900037-6

7 January 2021

Gelatinase B: a tuner and amplifier of immune functions.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2900037-6

7 January 2021

Gene deletions in patients with haemophilia B and anti-factor IX antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2900037-6

7 January 2021

Review--the use of immunosuppressive agents to prevent neutralizing antibodies against a transgene product

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2900037-6

7 January 2021

Use of a non-depleting anti-CD4 antibody to modulate the immune response to coagulation factors VIII and IX.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2900037-6

7 January 2021

Sustained high-level expression of human factor IX (hFIX) after liver-targeted delivery of recombinant adeno-associated virus encoding the hFIX gene in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2900037-6

7 January 2021

Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2900037-6

7 January 2021

Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2900037-6

7 January 2021

Use of autoantigen-knockout mice in developing an active autoimmune disease model for pemphigus

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2900037-6

7 January 2021

Analysis of Gelatinases in Complex Biological Fluids and Tissue Extracts

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2900037-6

7 January 2021

Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophosphamide, and factor VIII.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2900037-6

7 January 2021

Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2900037-6

7 January 2021

Neutralizing and binding antibodies to IFN-beta: relative frequency in relapsing-remitting multiple sclerosis patients treated with different IFN-beta preparations

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2900037-6

7 January 2021

Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN).

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2900037-6

7 January 2021

Clinical trials of antibody therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2900037-6

7 January 2021

Future prospects for vaccines to control fertility

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2900037-6

7 January 2021

C-C chemokine-encoding DNA vaccines enhance breakdown of tolerance to their gene products and treat ongoing adjuvant arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2900037-6

7 January 2021

Altering the genome by homologous recombination

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2900037-6

7 January 2021

Transcriptional activation by tetracyclines in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2900037-6

7 January 2021

A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2900037-6

7 January 2021

Initial sequencing and analysis of the human genome

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2900037-6

7 January 2021

The Sequence of the Human Genome

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2900037-6

7 January 2021

Continuous cultures of fused cells secreting antibody of predefined specificity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2900037-6

7 January 2021

With the benefit of hindsight

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2900037-6

7 January 2021

A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2900037-6

7 January 2021

10.1016/S1471-4906(02)00037-6

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12547507